prednisone has been researched along with Opportunistic Infections in 123 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
Excerpt | Relevance | Reference |
---|---|---|
"MTX, TNF antagonists and prednisone at doses >10 mg daily were associated with increased risks of overall infections." | 7.76 | Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. ( Bishai, W; Greenberg, JD; Hochberg, MC; Kavanaugh, A; Kremer, JM; Reed, G; Tindall, E; Zheng, C, 2010) |
"Newly diagnosed patients with multiple myeloma (MM) (n=122) aged greater than 55 yr, not eligible for transplantation were randomized to receive 8 cycles of M (9 mg/m(2) /d) and P (60 mg/m(2) /d) for 4d every 6 wk (n=62) or MP and thalidomide (100 mg/d) continuously (n=60)." | 6.76 | Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. ( Ali, R; Aydogdu, I; Beksac, M; Firatli-Tuglular, T; Goker, H; Gulbas, Z; Haznedar, R; Karakus, S; Kaya, E; Kaygusuz, I; Konuk, N; Ozdogu, H; Ozet, G; Sucak, G; Undar, L, 2011) |
" Here, we present the case of a 40-year-old male with severe ileocecal-CD who developed a reactivation of dermatomal herpes zoster after treatment with prednisone and adalimumab." | 4.89 | Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease. ( Fedorak, RN; Ma, C; Walters, B, 2013) |
" Clinical studies, registries, and case reports warn of the increased risk of infections, particularly opportunistic infections; however, already in the steroid monotherapy era, patients are at risk because it is accepted that a patient should be considered immunosuppressed when receiving a daily dose of 20 mg of prednisone for 2 weeks." | 4.88 | Risk of infection and prevention in pediatric patients with IBD: ESPGHAN IBD Porto Group commentary. ( de Ridder, L; Dias, JA; Escher, JC; Fell, J; Kolacek, S; Koletzko, S; Malmborg, P; Misak, Z; Rahier, JF; Veereman-Wauters, G; Veres, G, 2012) |
"MTX, TNF antagonists and prednisone at doses >10 mg daily were associated with increased risks of overall infections." | 3.76 | Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. ( Bishai, W; Greenberg, JD; Hochberg, MC; Kavanaugh, A; Kremer, JM; Reed, G; Tindall, E; Zheng, C, 2010) |
" The authors report a case of histoplasmosis presenting with signs of severe hypercalcemia and renal failure in a patient on infliximab for approximately three years in combination with low dosages of methotrexate and prednisone." | 3.76 | Atypical presentation of histoplasmosis in a patient with psoriasis and psoriatic arthritis on infliximab therapy. ( Kamili, Qu; Menter, A, 2010) |
" She had been receiving immunosuppressive therapy with methotrexate and prednisone for large-vessel vasculitis." | 3.76 | Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis. ( Battegay, M; Trendelenburg, M; Vetter, M, 2010) |
" In our patient, both polymyositis and steroid therapy were predisposing factors of cutaneous leishmaniasis onset; prednisone therapy has been postulated to be associated with immune dysfunction leading to: reduced blood T cells' levels (CD4 et CD8) as well as decreased cytokine synthesis (e." | 3.73 | [Cutaneous leishmaniasis in polymyositis]. ( Bernet, J; Courville, P; Favennec, L; Fevre, C; Levesque, H; Marie, I, 2006) |
" After two weeks of prednisone therapy, the patient developed prolonged fever, which was caused by CMV disseminated disease, with prompt clinical recovery after ganciclovir administration." | 3.72 | Disseminated cytomegalovirus disease as a cause of prolonged fever in a bullous pemphigoid patient under systemic steroid therapy. ( Aoki, V; Casals, DS; Correa, MC; Leite, OH; Maruta, CW; Nunes, Ede A; Rivitti, EA; Santi, CG; Simonsen Nico, MM, 2003) |
" A 52 year old woman is reported who was on long term treatment with chlorambucil and taking a short course of prednisone for familial CLL before she developed progressive dyspnoea, and P carinii pneumonia was diagnosed in bronchoalveolar lavage fluid." | 3.72 | Pneumocystis carinii pneumonia in chronic lymphocytic leukaemia. ( Halter, J; Hechelhammer, L; Himmelmann, A; Vavricka, SR, 2004) |
"Hypertension develops in most patients after transplantation when immunosuppression is based on cyclosporine and prednisone." | 3.68 | De novo hypertension after liver transplantation. ( Textor, SC, 1993) |
" He had the nephrotic syndrome for which he was on 60 mg prednisone daily." | 3.68 | Cutaneous phaeohyphomycosis due to Alternaria alternata responding to itraconazole. ( Coley, KE; Duffill, MB, 1993) |
"Seventeen cases of pneumonia occurring in renal transplantation patients treated with cyclosporine-prednisone immunosuppression were analyzed with regard to the organisms involved, time of occurrence after transplantation, clinical course, and radiographic findings." | 3.67 | Pulmonary infections in renal transplantation patients treated with cyclosporine. ( Amend, WJ; Moore, EH; Webb, WR, 1988) |
"Newly diagnosed patients with multiple myeloma (MM) (n=122) aged greater than 55 yr, not eligible for transplantation were randomized to receive 8 cycles of M (9 mg/m(2) /d) and P (60 mg/m(2) /d) for 4d every 6 wk (n=62) or MP and thalidomide (100 mg/d) continuously (n=60)." | 2.76 | Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. ( Ali, R; Aydogdu, I; Beksac, M; Firatli-Tuglular, T; Goker, H; Gulbas, Z; Haznedar, R; Karakus, S; Kaya, E; Kaygusuz, I; Konuk, N; Ozdogu, H; Ozet, G; Sucak, G; Undar, L, 2011) |
"Nocardiosis is an uncommon opportunistic infection seen in immunocompromised patients or those with a dysfunctional immune system." | 2.72 | Pulmonary nocardiosis in a patient with pemphigus foliaceus: case report and literature review. ( Chen, C; Chen, M; He, Y; Li, X; Liang, M; Liu, S; Luo, N; Singh, S; Tan, S; Yang, W, 2021) |
"MPA Cpredose and MPA AUC are significantly related to the incidence of biopsy-proven rejection after kidney transplantation, whereas MMF dose is significantly related to the occurrence of adverse events." | 2.69 | A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. ( de Fijter, JW; Hale, MD; Hené, RJ; Hilbrands, LB; Navarro, MT; Nicholls, AJ; Squifflet, JP; van Gelder, T; Vanrenterghem, Y; Verpooten, GA; Weimar, W, 1999) |
"Evans syndrome is a rare disorder characterized by combined autoimmune thrombocytopenia (ITP) and autoimmune hemolytic anemia (AIHA)." | 2.41 | Allogeneic stem cell transplantation for Evans syndrome. ( Burt, RK; Miranda, M; Oyama, Y; Papadopoulos, EB; Traynor, AE, 2001) |
"A case of Hodgkin's disease associated from the start with visceral leishmaniasis in the absence of antitumoral treatment shows that leishmaniasis is a severe opportunistic infection in endemic areas and can be masked by the tumoral syndrome of an underlying pathology." | 2.38 | [Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties]. ( Blanc, AP; Jacquème, P; Magnan, A; Poirier, R; Redding, E; Sudan, N, 1991) |
"Although rabbit anti-thymocyte globulin (rATG) is commonly used as induction therapy for kidney transplantation, dosing is not standardized." | 1.42 | Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients. ( Lee, E; Lee, S; Park, JM; Pennington, CA; Sindelar, J; Tischer, SM, 2015) |
"These infections included four cases of pneumocystosis, two cases of candidiasis, two cases of aspergillosis, two cases of cryptococcosis and one case of mucormycosis." | 1.39 | Invasive fungal infections in renal transplant recipients: about 11 cases. ( Ayadi, A; Charffedine, K; Cheikhrouhou, F; Guidara, R; Hachicha, J; Makni, F; Néji, S; Sellami, H; Trabelsi, H; Yaich, S, 2013) |
"Crusted Norwegian scabies is an extremely rare hyperkeratotic variant of scabies infestation." | 1.37 | Crusted Norwegian scabies, an opportunistic infection, with tocilizumab in rheumatoid arthritis. ( Aractingi, S; Baccouche, K; Berenbaum, F; Guegan, S; Sellam, J, 2011) |
"We report on a patient with Pneumocystis jirovecii pneumonia who developed fever, rash, eosinophilia and hepatitis 10 days after initiation of a therapy with sulfamethoxazole and trimethoprim." | 1.36 | [Rash, fever, eosinophilia and elevated liver enzymes. DRESS syndrome (drug reaction or rash with eosinophilia and systemic symptoms)]. ( Derungs, A; Kummer, O; Rätz Bravo, AE, 2010) |
"Kaposi's sarcoma is a vascular tumor caused by human herpesvirus-8 infection." | 1.36 | Kaposi's sarcoma: an opportunistic infection by human herpesvirus-8 in ulcerative colitis. ( de Francisco, R; Fernández-García, MS; García-Pravia, C; Gutiérrez-Corral, N; Riestra, S; Rodrigo, L; Rodríguez, JI; Rodríguez-Peláez, M, 2010) |
"She simultaneously developed pulmonary nocardiosis as well as a soft tissue infection and osteomyelitis by mycobacterium abscessus." | 1.35 | [Pulmonary nodules in a patient on long-term steroid treatment]. ( Bürgi, U; Hurni, Ch; Perrig, M; Rauch, A; Schoenenberger, AW; Trost, N, 2008) |
"We present a patient with chronic lymphocytic leukemia who died from Pneumocystis pneumonia (PCP) despite appropriate anti-Pneumocystis therapy." | 1.35 | Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment. ( Kovacs, JA; Masur, H, 2009) |
"Strongyloidiasis is epidemic in tropical and subtropical regions where the regional prevalence may exceed 25%." | 1.34 | Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-alpha therapy. ( Dincer, HE; Krishnamurthy, R; Whittemore, D, 2007) |
" Diagnosis was based on the very typical ocular feature combined with a positive blood or vitreous culture." | 1.33 | [Endogenous Candida endophthalmitis combined with severe general diseases]. ( Stoffelns, BM, 2005) |
"Lymphocytopenia has been reported in patients with connective tissue diseases, including dermatomyositis (DM)." | 1.32 | Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy. ( Bachelez, H; de la Salmonière, P; Dubertret, L; Fouéré, S; Lebbe, C; Morel, P; Rabian, C; Viguier, M, 2003) |
"A 48 year old patient with active Crohn's disease presented with bilateral nodules over his lungs resembling malignant metastasis." | 1.32 | Mycobacterium xenopi infection in an immunosuppressed patient with Crohn's disease. ( Majoor, CJ; Schreurs, AJ; Weers-Pothoff, G, 2004) |
"The other patient presented with upper gastrointestinal hemorrhage from a bleeding duodenal ulcer." | 1.31 | [Atypical cytomegalovirus in renal transplantation: a new form of presentation]. ( Campistol, JM; Cofán, F; Esforzado, N; Llach, J; Oppenheimer, F; Pérez-Valentín, MA; Solé, M, 2002) |
" Despite prompt initiation of antimycotic therapy the outcome was fatal; dosage of conventional and liposomal amphotericin B was limited due to treatment-related toxicities." | 1.31 | A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation. ( Bethe, U; Cornely, OA; Pels, H; Ritzkowsky, A; Seibold, M; Soehngen, D; Toepelt, K, 2001) |
"We describe the clinical presentation, treatment of Kaposi's sarcoma skin lesions in an immunosuppressed patient with bullous pemphigoid." | 1.30 | Identification of HHV-8 DNA in the skin lesions of Kaposi's sarcoma in an immunosuppressed patient with bullous pemphigoid. ( Gaspari, AA; Marchese, S; Powell, D; Rady, PL; Tyring, SK, 1997) |
"402 patients with chronic lymphocytic leukemia not previously treated or treated with chlorambucil (with or without prednisone) who received fludarabine (30 mg/m2 of body surface area per day for 5 days) with or without prednisone at 4-week intervals." | 1.30 | Infections in patients with chronic lymphocytic leukemia treated with fludarabine. ( Anaissie, EJ; Kantarjian, H; Keating, MJ; Kontoyiannis, DP; Lerner, S; O'Brien, S; Robertson, L, 1998) |
"Disseminated histoplasmosis is an unusual complication in endemic areas and has been reported in patients with an immunodeficient state, either from human immunodeficiency virus (HIV) infection or transplantation." | 1.30 | Disseminated histoplasmosis and Wegener's granulomatosis. ( Manepalli, AN; Rush, L, 1998) |
"A patient with systemic lupus erythematosus (SLE) developed primary subcutaneous nocardiosis during steroid and cyclophosphamide therapy for diffuse proliferative glomerulonephritis." | 1.30 | Primary subcutaneous nocardial infection in a SLE patient. ( Balbir-Gurman, A; Nahir, AM; Schapira, D, 1999) |
"We report the first case of nocardiosis in a recently transplanted renal patient maintained on tacrolimus, prednisone, and mycophenolate mofetil." | 1.30 | Nocardiosis in a recently transplanted renal patient. ( Holley, JL; Reddy, SS, 1998) |
"Although infectious esophagitis is usually due to infection with Candida, herpes virus, or cytomegalovirus, bacterial esophagitis is occasionally observed." | 1.29 | Bacterial esophagitis associated with CD4+ T-lymphocytopenia without HIV infection. Possible role of corticosteroid treatment. ( Orchard, JL; Richert, SM, 1995) |
"The primary skin lesion of pemphigus vulgaris which was often fatal before the introduction of systemic glucocorticoid therapy, is a flaccid, fragile blister which can occur anywhere." | 1.29 | Bilateral herpes simplex virus keratitis in a patient with pemphigus vulgaris. ( Takeshita, T, 1996) |
"Most aspects of Wegener granulomatosis were similar in childhood-onset and adult-onset patients." | 1.29 | Wegener granulomatosis in children and adolescents: clinical presentation and outcome. ( Fauci, AS; Hallahan, CW; Hoffman, GS; Kerr, GS; Leavitt, RY; Lebovics, R; Rottem, M, 1993) |
"A further case of listeriosis has recently been described in a man who developed the infection 2 years after successful fludarabine treatment while he had a normal CD4 lymphocyte count." | 1.29 | Late listeriosis after fludarabine plus prednisone treatment. ( Girmenia, C; Mauro, FR; Rahimi, S, 1994) |
"carinii pneumonia in patients with Wegener's granulomatosis." | 1.29 | Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. ( Fauci, AS; Hoffman, GS; Kerr, GS; Leavitt, RY; Ognibene, FP; Reda, D; Shelhamer, JH, 1995) |
"Proven Pneumocystis carinii pneumonia (PCP) occurred in 8 (5." | 1.29 | Pneumocystis carinii pneumonia after liver transplantation in adults. ( Hayes, MJ; McCaughan, GW; Sheil, AG; Torzillo, PJ, 1994) |
"We report a 49 years old woman with systemic lupus erythematosus and a WHO type IV nephropathy, treated with prednisone 1 mg/kg/day po and cyclophosphamide 1 g/month iv." | 1.29 | [Lupus erythematosus disseminatus and Pneumocystis carinii pneumonia]. ( Guzmán, L; Neira, O; Wainstein, E, 1993) |
"Temporal arteritis is a systemic necrotizing vasculitis for which the only effective treatment is systemic corticosteroids." | 1.29 | Invasive aspergillosis. A complication of treatment of temporal arteritis. ( Wiggins, RE, 1995) |
"Children with malignancy have a high incidence of pneumonia and pneumonitis and death is rare if the patient does not have terminal malignant disease." | 1.28 | Pneumonia and pneumonitis in childhood malignancy. ( Eden, OB; Elton, R; Shaw, NJ, 1992) |
"Sixty-three cases of Hodgkin's disease in intravenous drug users (IVDUs) have been collected by the Italian Cooperative Group on AIDS-Related Tumors (GICAT)." | 1.28 | Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT). ( Foà, R; Gavosto, F; Monfardini, S; Tirelli, U; Vaccher, E, 1991) |
"The course of Wegener granulomatosis has been dramatically improved by daily treatment with cyclophosphamide and glucocorticoids." | 1.28 | Wegener granulomatosis: an analysis of 158 patients. ( Fauci, AS; Hallahan, CW; Hoffman, GS; Kerr, GS; Leavitt, RY; Lebovics, RS; Rottem, M; Travis, WD, 1992) |
"Six had systemic lupus erythematosus and another had dermatomyositis and are described in detail." | 1.28 | Salmonella arizona arthritis and septicemia associated with rattlesnake ingestion by patients with connective tissue diseases. A dangerous complication of folk medicine. ( Alarcón-Segovia, D; Guerra-Bautista, G; Kraus, A, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (5.69) | 18.7374 |
1990's | 45 (36.59) | 18.2507 |
2000's | 37 (30.08) | 29.6817 |
2010's | 29 (23.58) | 24.3611 |
2020's | 5 (4.07) | 2.80 |
Authors | Studies |
---|---|
Shah, NJ | 1 |
Cook, MR | 1 |
Wu, T | 1 |
Lev-Ari, S | 1 |
Blackburn, MJ | 1 |
Serzan, MT | 1 |
Alaoui, A | 1 |
Ahn, J | 1 |
Atkins, MB | 1 |
Braud, A | 1 |
Wurth, S | 1 |
Leblanc, S | 1 |
Mahé, A | 1 |
Serrano, OK | 1 |
Kutzler, HL | 1 |
Rochon, C | 1 |
Radojevic, JA | 1 |
Lawlor, MT | 1 |
Hammond, JA | 1 |
Gluck, J | 1 |
Feingold, AD | 1 |
Jaiswal, A | 1 |
Wang, H | 1 |
Zhao, Y | 1 |
Zhang, X | 1 |
Si, X | 1 |
Song, P | 1 |
Xiao, Y | 1 |
Yang, X | 1 |
Song, L | 1 |
Shi, J | 1 |
Zhao, H | 1 |
Zhang, L | 1 |
Luo, N | 1 |
Tan, S | 1 |
Li, X | 1 |
Liu, S | 1 |
Singh, S | 1 |
Chen, M | 1 |
Yang, W | 1 |
He, Y | 1 |
Chen, C | 1 |
Liang, M | 1 |
Dameron, M | 1 |
Horowitz, M | 1 |
Gupta, N | 1 |
Abi Hatem, N | 1 |
Garner, O | 1 |
Ramirez-Berlioz, A | 1 |
Iardino, A | 1 |
Mocherla, S | 1 |
Bhairavarasu, K | 1 |
Mahajan, KR | 1 |
Kobayashi, T | 1 |
Ford, B | 1 |
Sekar, P | 1 |
Ma, C | 1 |
Walters, B | 1 |
Fedorak, RN | 1 |
Trabelsi, H | 1 |
Néji, S | 1 |
Sellami, H | 1 |
Yaich, S | 1 |
Cheikhrouhou, F | 1 |
Guidara, R | 1 |
Charffedine, K | 1 |
Makni, F | 1 |
Hachicha, J | 1 |
Ayadi, A | 1 |
Lauten, M | 1 |
Güttel, C | 1 |
Härtel, C | 1 |
Erdlenbruch, B | 1 |
Garrido Colmenero, C | 1 |
Arias Santiago, S | 1 |
Blasco Morente, G | 1 |
Martín Castro, A | 1 |
Leshem, YA | 1 |
Gdalevich, M | 1 |
Ziv, M | 1 |
David, M | 1 |
Hodak, E | 1 |
Mimouni, D | 1 |
Malkan, AD | 1 |
Wahid, FN | 1 |
Rao, BN | 1 |
Sandoval, JA | 1 |
Pennington, CA | 1 |
Tischer, SM | 1 |
Lee, E | 1 |
Lee, S | 1 |
Sindelar, J | 1 |
Park, JM | 1 |
Matschke, J | 1 |
Müller-Beissenhirtz, H | 1 |
Novotny, J | 1 |
Vester, I | 1 |
Hertenstein, B | 1 |
Eisele, L | 1 |
Lax, H | 1 |
Ose, C | 1 |
Dührsen, U | 1 |
Hurni, Ch | 1 |
Rauch, A | 1 |
Trost, N | 1 |
Perrig, M | 1 |
Bürgi, U | 1 |
Schoenenberger, AW | 1 |
Khellaf, M | 1 |
Godeau, B | 2 |
Rubia, MF | 1 |
Chozas, N | 1 |
García-Martos, P | 1 |
Reyes, F | 1 |
Greenberg, JD | 1 |
Reed, G | 1 |
Kremer, JM | 1 |
Tindall, E | 1 |
Kavanaugh, A | 1 |
Zheng, C | 1 |
Bishai, W | 1 |
Hochberg, MC | 1 |
Cerceo, E | 1 |
Kotloff, RM | 1 |
Hadjiliadis, D | 1 |
Ahya, VN | 1 |
Pochettino, A | 1 |
Gillespie, C | 1 |
Christie, JD | 1 |
Kovacs, JA | 1 |
Masur, H | 1 |
Jurawan, R | 1 |
de Almeida, M | 1 |
Smith, A | 1 |
Weilert, F | 1 |
Isenberg, D | 1 |
Appel, GB | 1 |
Contreras, G | 1 |
Dooley, MA | 1 |
Ginzler, EM | 1 |
Jayne, D | 1 |
Sánchez-Guerrero, J | 1 |
Wofsy, D | 1 |
Yu, X | 1 |
Solomons, N | 1 |
Kamili, Qu | 1 |
Menter, A | 1 |
Vetter, M | 1 |
Battegay, M | 1 |
Trendelenburg, M | 1 |
Bonnet, N | 1 |
Guis, S | 1 |
Drancourt, M | 1 |
Brouqui, P | 1 |
Berbis, P | 1 |
Derungs, A | 1 |
Rätz Bravo, AE | 1 |
Kummer, O | 1 |
Beksac, M | 1 |
Haznedar, R | 2 |
Firatli-Tuglular, T | 1 |
Ozdogu, H | 1 |
Aydogdu, I | 1 |
Konuk, N | 1 |
Sucak, G | 1 |
Kaygusuz, I | 1 |
Karakus, S | 1 |
Kaya, E | 1 |
Ali, R | 1 |
Gulbas, Z | 1 |
Ozet, G | 1 |
Goker, H | 1 |
Undar, L | 1 |
Rodríguez-Peláez, M | 1 |
Fernández-García, MS | 1 |
Gutiérrez-Corral, N | 1 |
de Francisco, R | 1 |
Riestra, S | 1 |
García-Pravia, C | 1 |
Rodríguez, JI | 1 |
Rodrigo, L | 1 |
Baccouche, K | 1 |
Sellam, J | 1 |
Guegan, S | 1 |
Aractingi, S | 1 |
Berenbaum, F | 1 |
Efthimiou, P | 1 |
Pokharna, H | 1 |
Kukar, M | 1 |
Hennessey, K | 1 |
Hemmaway, C | 1 |
Laverse, E | 1 |
Nicholas, M | 1 |
Nagy, Z | 1 |
Dai, W | 1 |
Dharamsi, JW | 1 |
Soliman, S | 1 |
Ricotti, C | 1 |
Gander, R | 1 |
Bergstresser, P | 1 |
Chan, J | 1 |
Kaswan, KK | 1 |
Vanikar, AV | 1 |
Feroz, A | 1 |
Patel, HV | 1 |
Gumber, M | 1 |
Trivedi, HL | 1 |
Li, F | 1 |
Jin, HZ | 1 |
Su, F | 1 |
Jia, L | 1 |
Sun, QN | 1 |
Veereman-Wauters, G | 1 |
de Ridder, L | 1 |
Veres, G | 1 |
Kolacek, S | 1 |
Fell, J | 1 |
Malmborg, P | 1 |
Koletzko, S | 1 |
Dias, JA | 1 |
Misak, Z | 1 |
Rahier, JF | 1 |
Escher, JC | 1 |
Kim, T | 1 |
Choi, SH | 1 |
Kim, SH | 1 |
Jeong, JY | 1 |
Woo, JH | 1 |
Kim, YS | 1 |
Sung, H | 1 |
Kim, MN | 1 |
Yoon, DH | 1 |
Suh, C | 1 |
Lee, SO | 1 |
Williams, MS | 1 |
Ali, N | 1 |
Nonaka, D | 1 |
Bloor, AJ | 1 |
Somervaille, TC | 1 |
MacMillan, ML | 1 |
Weisdorf, DJ | 1 |
Wagner, JE | 1 |
DeFor, TE | 1 |
Burns, LJ | 1 |
Ramsay, NK | 1 |
Davies, SM | 1 |
Blazar, BR | 1 |
Pérez-Valentín, MA | 1 |
Cofán, F | 1 |
Solé, M | 1 |
Llach, J | 1 |
Esforzado, N | 1 |
Campistol, JM | 1 |
Oppenheimer, F | 1 |
Jastrzembski, SA | 1 |
Teirstein, AS | 1 |
Herman, SD | 1 |
DePalo, LR | 1 |
Lento, PA | 1 |
Krebs, M | 1 |
Watschinger, B | 1 |
Brunner, C | 1 |
Hassl, A | 1 |
Base, W | 1 |
Seifert, B | 1 |
Favre, G | 1 |
Viguier, M | 1 |
Fouéré, S | 1 |
de la Salmonière, P | 1 |
Rabian, C | 1 |
Lebbe, C | 1 |
Dubertret, L | 1 |
Morel, P | 1 |
Bachelez, H | 1 |
Casals, DS | 1 |
Nunes, Ede A | 1 |
Maruta, CW | 1 |
Aoki, V | 1 |
Santi, CG | 1 |
Simonsen Nico, MM | 1 |
Correa, MC | 1 |
Leite, OH | 1 |
Rivitti, EA | 1 |
Gentil, B | 1 |
Cottin, V | 1 |
Girard, P | 1 |
Cordier, JF | 1 |
Vavricka, SR | 1 |
Halter, J | 1 |
Hechelhammer, L | 1 |
Himmelmann, A | 1 |
Suárez Ortega, S | 1 |
Campos-Herrero Navas, MI | 1 |
Limeres González, MA | 1 |
Díaz López, F | 1 |
Zarzalejos Andes, JM | 1 |
Arkuch Saade, ME | 1 |
Majoor, CJ | 1 |
Schreurs, AJ | 1 |
Weers-Pothoff, G | 1 |
Arunkumar, P | 1 |
Crook, T | 1 |
Ballard, J | 1 |
Tanaka, Y | 1 |
Singh, SM | 1 |
Rau, NV | 1 |
Cohen, LB | 1 |
Harris, H | 1 |
Stoffelns, BM | 1 |
Baughman, RP | 2 |
Lower, EE | 1 |
Kalkanci, A | 1 |
Kokturk, N | 1 |
Senol, E | 1 |
Acar, K | 1 |
Guzel, O | 1 |
Sancak, B | 1 |
Kustimur, S | 1 |
Rowin, J | 1 |
Amato, AA | 1 |
Deisher, N | 1 |
Cursio, J | 1 |
Meriggioli, MN | 1 |
Marie, I | 1 |
Fevre, C | 1 |
Favennec, L | 1 |
Courville, P | 1 |
Bernet, J | 1 |
Levesque, H | 1 |
Riera-Mestre, A | 1 |
de la Haba-Vacas, I | 1 |
Vidaller-Palacín, A | 1 |
Fernández-Viladrich, P | 1 |
Krishnamurthy, R | 1 |
Dincer, HE | 1 |
Whittemore, D | 1 |
Ekberg, H | 1 |
Tedesco-Silva, H | 1 |
Demirbas, A | 1 |
Vítko, S | 1 |
Nashan, B | 1 |
Gürkan, A | 1 |
Margreiter, R | 1 |
Hugo, C | 1 |
Grinyó, JM | 1 |
Frei, U | 1 |
Vanrenterghem, Y | 2 |
Daloze, P | 1 |
Halloran, PF | 1 |
Peacock, JE | 1 |
Greven, CM | 1 |
Cruz, JM | 1 |
Hurd, DD | 1 |
Faulk, CT | 1 |
Lesher, JL | 1 |
Sneller, MC | 1 |
Hoffman, GS | 4 |
Talar-Williams, C | 1 |
Kerr, GS | 4 |
Hallahan, CW | 3 |
Fauci, AS | 4 |
Wiggins, RE | 1 |
Richert, SM | 1 |
Orchard, JL | 1 |
Hayes, MJ | 1 |
Torzillo, PJ | 1 |
Sheil, AG | 1 |
McCaughan, GW | 1 |
Ognibene, FP | 1 |
Shelhamer, JH | 1 |
Reda, D | 1 |
Leavitt, RY | 3 |
Scalzini, A | 1 |
Barni, C | 1 |
Stellini, R | 1 |
Sueri, L | 1 |
Gehrke, D | 1 |
Herzum, M | 1 |
Schönian, U | 1 |
Klein, HH | 1 |
Drude, L | 1 |
Mennel, HD | 1 |
Maisch, B | 1 |
Girmenia, C | 1 |
Mauro, FR | 1 |
Rahimi, S | 1 |
Peral, V | 1 |
Vidau, P | 1 |
Herrera, J | 1 |
Rodriguez, C | 1 |
Tricas, L | 1 |
Tomé, R | 1 |
Arroyo, F | 1 |
Fang, J | 1 |
Viksman, MY | 1 |
Ebisawa, M | 1 |
Bochner, BS | 1 |
Machet, MC | 1 |
Stephanov, E | 1 |
Estève, E | 1 |
De Closets, F | 1 |
Barrabès, A | 1 |
Thérizol-Ferly, M | 1 |
Lebret, G | 1 |
Grangeponte, MC | 1 |
Vaillant, L | 1 |
Schaller, J | 1 |
Rohwedder, A | 1 |
Breier, B | 1 |
Werchau, H | 1 |
Wainstein, E | 1 |
Neira, O | 1 |
Guzmán, L | 1 |
Coutant-Perronne, V | 1 |
Le Thi Huong, D | 1 |
Guillevin, L | 1 |
Magadur, G | 1 |
De Bandt, M | 1 |
Dellion, S | 1 |
Rossert, J | 1 |
Rostoker, G | 1 |
Piette, JC | 1 |
Textor, SC | 1 |
Rottem, M | 2 |
Lebovics, R | 1 |
Duffill, MB | 1 |
Coley, KE | 1 |
Shield, CF | 1 |
Jacobs, RJ | 1 |
Wyant, S | 1 |
Das, A | 1 |
Takeshita, T | 1 |
Hedderwick, SA | 1 |
Bonilla, HF | 1 |
Bradley, SF | 1 |
Kauffman, CA | 1 |
Gaspari, AA | 1 |
Marchese, S | 1 |
Powell, D | 1 |
Rady, PL | 1 |
Tyring, SK | 1 |
Mookerjee, BP | 1 |
Vogelsang, G | 1 |
Mohammedi, I | 1 |
Vedrinne, JM | 1 |
Floccard, B | 1 |
Reverdy, ME | 1 |
Duperret, S | 1 |
Motin, J | 1 |
Pareja, JG | 1 |
Garland, R | 1 |
Koziel, H | 1 |
Poveda, F | 1 |
García-Alegría, J | 1 |
de las Nieves, MA | 1 |
Villar, E | 1 |
Montiel, N | 1 |
del Arco, A | 1 |
Reddy, SS | 1 |
Holley, JL | 1 |
Anaissie, EJ | 1 |
Kontoyiannis, DP | 1 |
O'Brien, S | 1 |
Kantarjian, H | 1 |
Robertson, L | 1 |
Lerner, S | 1 |
Keating, MJ | 1 |
Sarmiento, JM | 1 |
Munn, SR | 1 |
Paya, CV | 1 |
Velosa, JA | 1 |
Nguyen, JH | 1 |
Manepalli, AN | 1 |
Rush, L | 1 |
Schnader, J | 1 |
Pina, EM | 1 |
Glassroth, J | 1 |
Adebonojo, S | 1 |
Wang, BY | 1 |
Krishnan, S | 1 |
Isenberg, HD | 1 |
Balbir-Gurman, A | 1 |
Schapira, D | 1 |
Nahir, AM | 1 |
van Gelder, T | 1 |
Hilbrands, LB | 1 |
Weimar, W | 1 |
de Fijter, JW | 1 |
Squifflet, JP | 1 |
Hené, RJ | 1 |
Verpooten, GA | 1 |
Navarro, MT | 1 |
Hale, MD | 1 |
Nicholls, AJ | 1 |
Tirelli, U | 2 |
Vaccher, E | 2 |
Spina, M | 1 |
Carbone, A | 1 |
Martel, J | 1 |
Faisant, M | 1 |
Lebeau, B | 1 |
Pinel, C | 1 |
Feray, C | 1 |
Feuilhade, M | 1 |
Staskewitz, A | 1 |
Kirste, G | 1 |
Tönshoff, B | 1 |
Weber, LT | 1 |
Böswald, M | 1 |
Burghard, R | 1 |
Helmchen, U | 1 |
Brandis, M | 1 |
Zimmerhackl, LB | 1 |
Cornely, OA | 1 |
Pels, H | 1 |
Bethe, U | 1 |
Seibold, M | 1 |
Toepelt, K | 1 |
Soehngen, D | 1 |
Ritzkowsky, A | 1 |
Oyama, Y | 1 |
Papadopoulos, EB | 1 |
Miranda, M | 1 |
Traynor, AE | 1 |
Burt, RK | 1 |
Touahri, T | 1 |
Pulik, M | 1 |
Fezoui, H | 1 |
Genet, P | 1 |
Lionnet, F | 1 |
Louvel, D | 1 |
Facundo, C | 1 |
Diaz, JM | 1 |
Guirado, L | 1 |
Duran, F | 1 |
Herreros, MA | 1 |
Diaz, M | 1 |
Sola, R | 1 |
Vivancos, J | 1 |
Vila, M | 1 |
Serra, A | 1 |
Loscos, J | 1 |
Anguita, A | 1 |
Brownstein, S | 1 |
Vine, AK | 1 |
Rokicka-Milewska, R | 1 |
Pacholska, J | 1 |
Lukowska, K | 1 |
Paciorkiewicz, W | 1 |
Jastrzebska, M | 1 |
Shaw, NJ | 1 |
Elton, R | 1 |
Eden, OB | 1 |
Rodrigues, J | 1 |
Niederman, MS | 1 |
Fein, AM | 1 |
Pai, PB | 1 |
Monfardini, S | 1 |
Foà, R | 1 |
Gavosto, F | 1 |
Magnan, A | 1 |
Jacquème, P | 1 |
Sudan, N | 1 |
Redding, E | 1 |
Blanc, AP | 1 |
Poirier, R | 1 |
Lebovics, RS | 1 |
Travis, WD | 1 |
Kraus, A | 1 |
Guerra-Bautista, G | 1 |
Alarcón-Segovia, D | 1 |
Pohl, MA | 1 |
Lan, SP | 1 |
Berl, T | 1 |
Murdock, DK | 1 |
Lookingbill, DP | 1 |
Escobar, A | 1 |
Del Brutto, OH | 1 |
Stratta, RJ | 1 |
D'Alessandro, AM | 1 |
Armbrust, MJ | 1 |
Pirsch, JD | 1 |
Sollinger, HW | 1 |
Kalayoglu, M | 1 |
Belzer, FO | 1 |
Wiest, PM | 1 |
Flanigan, T | 1 |
Salata, RA | 1 |
Shlaes, DM | 1 |
Katzman, M | 1 |
Lederman, MM | 1 |
Moore, EH | 1 |
Webb, WR | 1 |
Amend, WJ | 1 |
Arnfred, J | 1 |
Nielsen, CM | 1 |
Spencer, ES | 1 |
Andersen, HK | 1 |
Segoloni, GP | 1 |
Messina, M | 1 |
Colla, L | 1 |
Piccoli, GB | 1 |
Triolo, G | 1 |
Vercellone, A | 1 |
Hancock, SL | 1 |
Hoppe, RT | 1 |
Horning, SJ | 1 |
Rosenberg, SA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Studies of Human Pneumocystis Infection[NCT00342589] | 1,500 participants (Anticipated) | Observational | 1999-09-28 | Recruiting | |||
A Prospective, Randomized, Active Controlled, Parallel Group, Multi-center Trial to Assess the Efficacy and Safety of Mycophenolate Mofetil (MMF) in Inducing Response and Maintaining Remission in Subjects With Lupus Nephritis.[NCT00377637] | Phase 3 | 370 participants (Actual) | Interventional | 2005-07-31 | Completed | ||
Phase III Trial Comparing Treatment With Melphalan+Prednisolon (MP) With Melphalan+Prednisolon+Thalidomide (MPT) for Previously Untreated Elderly Patients With Multiple Myeloma[NCT00934154] | Phase 3 | 122 participants (Actual) | Interventional | 2006-03-31 | Completed | ||
A Pilot Study on the Efficacy of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive by Next Generation Flow[NCT03992170] | Phase 2 | 50 participants (Anticipated) | Interventional | 2018-12-31 | Recruiting | ||
A Prospective, Observational Study, to Evaluate the Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for[NCT05218603] | 100 participants (Anticipated) | Observational | 2021-11-30 | Recruiting | |||
Development and Validation of New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma in CYP3A5 Expressors and Non-Expressors[NCT04657562] | 380 participants (Anticipated) | Observational [Patient Registry] | 2020-08-01 | Recruiting | |||
Evaluating Safety and Efficacy of MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Combination With Low-Dose CsA, Tac or Sir in Comparison to Current Standard Immunosuppression (MMF, CsA and Corticosteroids) in Renal Tx[NCT00231764] | Phase 4 | 1,760 participants | Interventional | 2002-11-30 | Completed | ||
Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma: a Randomized Controlled Trial[NCT04448873] | Phase 4 | 30 participants (Actual) | Interventional | 2020-07-01 | Completed | ||
A Staged Therapeutic Approach Using Cyclophosphamide and Methotrexate in the Treatment of Wegener's Granulomatosis and Related Vasculitides[NCT00001473] | 100 participants | Observational | 1995-03-31 | Completed | |||
An Open Trial of the Efficacy of Glucocorticoids and Methotrexate (MTX) in the Treatment of Systemic Vasculitis[NCT00001256] | Phase 2 | 100 participants | Interventional | 1990-03-31 | Completed | ||
Pilot Trial for Implementation of a MPA PK Monitoring Strategy[NCT00187915] | 24 participants (Actual) | Interventional | 2003-07-31 | Completed | |||
An Open, Prospective, Randomised, Controlled, Multi-Center Study Comparing Fixed Dose vs Concentration Controlled Mycophenolate Mofetil Regimens for de Novo Patients Following Transplantation[NCT00166244] | Phase 4 | 901 participants (Actual) | Interventional | 2003-05-31 | Completed | ||
An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies[NCT00072592] | Phase 1 | 10 participants | Interventional | 2003-10-31 | Completed | ||
Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis[NCT02626845] | Phase 4 | 3 participants (Actual) | Interventional | 2015-12-31 | Terminated (stopped due to Slow recruitment) | ||
Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis[NCT00001761] | Phase 1 | 15 participants | Interventional | 1998-02-28 | Completed | ||
Treatment of Wegener's Granulomatosis With Cyclophosphamide[NCT00001155] | Phase 2 | 200 participants | Interventional | 1976-02-29 | Completed | ||
Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides. A Randomized Controlled Trial.[NCT00751517] | Phase 2 | 0 participants | Interventional | Active, not recruiting | |||
A Randomized Trial Comparing Methotrexate Versus Mycophenolate Mofetil for Remission Maintenance in Wegener's Granulomatosis and Related Vasculitides[NCT00004567] | Phase 2 | 75 participants | Interventional | 2000-02-29 | Completed | ||
Phase I/II Trial of TNFR:Fc (Etanercept) in Patients With Wegener's Granulomatosis[NCT00001901] | Phase 2 | 60 participants | Interventional | 1999-02-28 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Treatment Failure was adjudicated by a clinical endpoints committee (CEC) and was defined as the time to the earliest occurrence of any one of the following: death, end stage renal disease, sustained doubling of serum creatinine, renal flare, or a requirement for rescue therapy for exacerbation or deterioration of Lupus nephritis (LN). (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36
Intervention | Deaths (Number) |
---|---|
Mycophenolate Mofetil (MMF) | 0 |
Azathioprine (AZA) | 1 |
Time to treatment failure, adjudicated by the Clinical Endpoints Committee (CEC), was defined as any 1 the following: death, ESRD, sustained doubling of serum creatinine, renal flare (proteinuric or nephritic), or requirement for rescue therapy to treat deterioration or exacerbation of Lupus nephritis. ESRD is defined as progression to chronic hemodialysis or renal transplant. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36
Intervention | participants (Number) |
---|---|
Mycophenolate Mofetil (MMF) | 0 |
Azathioprine (AZA) | 3 |
Sustained doubling of serum creatinine concentration is defined as the first serum creatinine value that is twice the mean of the lowest 2 values from screening to end of induction, as confirmed by a second serum creatinine value obtained at least 4 weeks after the initial doubling. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36
Intervention | participants (Number) |
---|---|
Mycophenolate Mofetil | 1 |
Azathioprine | 5 |
A major extra-renal flare is defined as a British Isles Lupus Assessment Group (BILAG) Score category A in one extrarenal organ or three organs with concurrent category B scores. BILAG indices provide a scoring system for the assessment of lupus disease activity in terms of the need for steroid treatment in 8 organs/systems. Eighty-six items were scored resulting in a classification of A (severe activity), B (moderate activity), C (mild activity), D (no current activity) and E (no activity ever observed) for each organ system. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36
Intervention | participants (Number) |
---|---|
Mycophenolate Mofetil | 7 |
Azathioprine | 6 |
The SF-36 is a 36 item quality of life questionnaire. The short-form version has eleven questions that permit the participant to rate how they feel that particular day. The SF-36 consists of eight scaled scores and two component scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 score with the higher scores indicating better quality of life. (NCT00377637)
Timeframe: Baseline and 24 weeks
Intervention | Scores on a scale (Mean) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Physical Component Summary [n=139, 137] | Mental Component Summary [n=139, 137] | Bodily Pain Score [n=141, 137] | General Health Score [n=139, 137] | Mental Health Score [n=141, 137] | Physical functioning Score [n=141, 137] | Role-Emotional Score [n=141, 137] | Role-Physical Score [n=141, 137] | Social Function Score [n=141, 137] | Vitality Score [n=141, 137] | |
Intravenous Cyclophosphamide | 6.4 | 5.7 | 16.8 | 11.5 | 9.8 | 9.3 | 18.4 | 34.0 | 18.2 | 11.6 |
Mycophenolate Mofetil | 5.2 | 6.7 | 13.4 | 9.1 | 9.3 | 11.6 | 23.4 | 28.6 | 17.7 | 14.2 |
24-hour urine protein was measured at Baseline and Week 24. (NCT00377637)
Timeframe: Baseline, Week 24
Intervention | mg/day (Mean) | ||
---|---|---|---|
Baseline [n=180, 180] | Week 24 [n= 150, 144] | Change from Baseline to Week 24 [n= 146, 142] | |
Intravenous Cyclophosphamide | 4451.4 | 1831.6 | -2513.7 |
Mycophenolate Mofetil | 4208.9 | 1599.0 | -2510.6 |
(NCT00377637)
Timeframe: Baseline, Week 24
Intervention | g/L (Mean) | ||
---|---|---|---|
Baseline [n=184, 185] | Week 24 [n=155, 151] | Change from Baseline to Week 24 [n=154, 151] | |
Intravenous Cyclophosphamide | 28.6 | 38.3 | 9.0 |
Mycophenolate Mofetil | 30.5 | 38.4 | 7.5 |
(NCT00377637)
Timeframe: Baseline, Week 24
Intervention | µmol/L (Mean) | ||
---|---|---|---|
Baseline [n= 184, 185] | Week 24 [n= 155, 151] | Change from Baseline to Week 24 [n= 154, 151] | |
Intravenous Cyclophosphamide | 92.7 | 83.5 | -5.1 |
Mycophenolate Mofetil | 108.6 | 77.6 | -18.9 |
"BILAG indices provide a scoring system for the assessment of lupus disease activity in terms of the need for steroid treatment in 8 organs/systems. Eighty-six items were scored resulting in a classification of A (severe activity), B (moderate activity), C (mild activity), D (no current activity) and E (no activity ever observed) for each organ system. The BILAG individual system summaries were calculated by a program supplied by ADS-Limathon (Sheffield, UK).~The score at baseline was compared to the score at the 24 week endpoint for each treatment group, reported here for the renal system." (NCT00377637)
Timeframe: Baseline, 24 weeks
Intervention | Percentage of participants (Number) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shift from Baseline=A to 24 Week Endpoint=A | Shift from Baseline=A to 24 Week Endpoint=B | Shift from Baseline=A to 24 Week Endpoint=C | Shift from Baseline=A to 24 Week Endpoint=D | Shift from Baseline=B to 24 Week Endpoint=A | Shift from Baseline=B to 24 Week Endpoint=B | Shift from Baseline=B to 24 Week Endpoint=C | Shift from Baseline=B to 24 Week Endpoint=D | Shift from Baseline=C to 24 Week Endpoint=A | Shift from Baseline=C to 24 Week Endpoint=B | Shift from Baseline=C to 24 Week Endpoint=C | Shift from Baseline=C to 24 Week Endpoint=D | Shift from Baseline=D to 24 Week Endpoint=A | Shift from Baseline=D to 24 Week Endpoint=B | Shift from Baseline=D to 24 Week Endpoint=C | Shift from Baseline=D to 24 Week Endpoint=D | |
Intravenous Cyclophosphamide | 27.1 | 34.8 | 24.9 | 9.4 | 0.0 | 1.1 | 1.7 | 0.0 | 0.0 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.6 | 0.0 |
Mycophenolate Mofetil | 17.1 | 39.2 | 33.1 | 5.5 | 0.0 | 1.7 | 2.2 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Number of participants achieving complete remission as defined by return to normal serum creatinine, proteinuria ≤500 mg/24 hours and an inactive urinary sediment (absence of red blood cells, white blood cells or cellular or granular casts) after 24 weeks. (NCT00377637)
Timeframe: 24 weeks
Intervention | participants (Number) | |
---|---|---|
Complete Remission - Yes | Complete Remission - No | |
Intravenous Cyclophosphamide | 15 | 170 |
Mycophenolate Mofetil | 16 | 169 |
Treatment response was adjudicated by a blinded clinical endpoints committee (CEC) and defined as: a) Decrease in proteinuria, defined as a decrease in the urine protein to creatinine ratio (UPCr) to <3 in subjects with baseline proteinuria ≥3 UPCr or a decrease in the UPCr by ≥50% in subjects with proteinuria <3 UPCr at Baseline, and b) Stabilization of serum creatinine or improvement. UPCr were derived from the 24 hour urine collection. Patients who did not show a treatment response at Week 24 or who withdrew earlier than Week 24 were considered non-responders. (NCT00377637)
Timeframe: 24 weeks
Intervention | participants (Number) | |
---|---|---|
Responder | Non-responder | |
Intravenous Cyclophosphamide | 98 | 87 |
Mycophenolate Mofetil | 104 | 81 |
The primary efficacy parameter was the time to treatment failure, adjudicated by the Clinical Endpoints Committee (CEC), defined as any of the following: death, end stage renal disease, sustained doubling of serum creatinine, renal flare, or requirement for rescue therapy to treat deterioration or exacerbation of Lupus nephritis. Kaplan-Meier survival curves were estimated from the observed time to rescue treatment for each patient. The data presented are the percentage of participants who were rescue treatment free at each time interval as estimated by Kaplan-Meier. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36
Intervention | Percentage of participants (Number) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Start of Maintenance Phase to Month 3 | Month 3 to Month 6 | Month 6 to Month 9 | Month 9 to Month 12 | Month 12 to Month 15 | Month 15 to Month 18 | Month 18 to Month 21 | Month 21 to Month 24 | Month 24 to Month 27 | Month 27 to Month 30 | Month 30 to Month 33 | Month 33 to Month 36 | |
Azathioprine | 99.1 | 95.1 | 93.0 | 91.9 | 88.4 | 87.1 | 83.1 | 83.1 | 81.7 | 80.3 | 78.8 | 75.9 |
Mycophenolate Mofetil | 100 | 98.2 | 97.2 | 94.2 | 94.2 | 94.2 | 93.1 | 91.9 | 90.8 | 90.8 | 90.8 | 90.8 |
A proteinuric flare is defined as a doubling of the urine protein:creatinine ratio, and proteinuria ≥1 g/24 h in patients with urine protein ≤0.5 g/24 h at the end of the induction phase, or proteinuria ≥2 g/24 h if urine protein was >0.5 g/24 h at the end of the induction phase. A nephritic flare is defined as a 25% increase in serum creatinine accompanied by 1 or more of the following: (a) simultaneous doubling of the proteinuria reaching a minimum of 2 g/24 h (b) new/increased hematuria or (c) the appearance of cellular casts. All flares were adjudicated by a clinical endpoints committee. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36
Intervention | Percentage of participants (Number) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Start of Maintenance Phase to Month 3 | Month 3 to Month 6 | Month 6 to Month 9 | Month 9 to Month 12 | Month 12 to Month 15 | Month 15 to Month 18 | Month 18 to Month 21 | Month 21 to Month 24 | Month 24 to Month 27 | Month 27 to Month 30 | Month 30 to Month 33 | Month 33 to Month 36 | |
Azathioprine | 97.2 | 90.3 | 87.2 | 85.0 | 82.8 | 79.2 | 78.0 | 75.5 | 74.2 | 74.2 | 72.9 | 70.1 |
Mycophenolate Mofetil | 98.2 | 94.6 | 90.8 | 87.8 | 87.8 | 86.8 | 86.8 | 86.8 | 86.8 | 86.8 | 85.6 | 85.6 |
Treatment Failure was adjudicated by a clinical endpoints committee and was defined as the time to the earliest occurrence of any one of the following: death, end stage renal disease, sustained doubling of serum creatinine, renal flare, or a requirement for rescue therapy for exacerbation or deterioration of Lupus nephritis. Kaplan-Meier survival curves were estimated from the observed time to treatment failure for each patient. The data presented are the percentage of participants who were treatment-failure free at each time interval as estimated by Kaplan-Meier. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36
Intervention | Percentage of participants (Number) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Start of Maintenance Phase to Month 3 | Month 3 to Month 6 | Month 6 to Month 9 | Month 9 to Month 12 | Month 12 to Month 15 | Month 15 to Month 18 | Month 18 to Month 21 | Month 21 to Month 24 | Month 24 to Month 27 | Month 27 to Month 30 | Month 30 to Month 33 | Month 33 to Month 36 | |
Azathioprine | 97.2 | 89.3 | 86.2 | 83.0 | 77.5 | 74.1 | 70.7 | 68.3 | 67.1 | 65.9 | 63.4 | 58.6 |
Mycophenolate Mofetil | 98.2 | 93.7 | 89.9 | 86.0 | 86.0 | 84.9 | 84.9 | 83.9 | 82.8 | 82.8 | 81.7 | 81.7 |
10 reviews available for prednisone and Opportunistic Infections
Article | Year |
---|---|
Pulmonary nocardiosis in a patient with pemphigus foliaceus: case report and literature review.
Topics: Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Humans; Immunocompromised Host; Male; Middle Ag | 2021 |
Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease.
Topics: Acyclovir; Adalimumab; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Humanized; Antiviral | 2013 |
Risk of infection and prevention in pediatric patients with IBD: ESPGHAN IBD Porto Group commentary.
Topics: Antibodies, Monoclonal; Drug Therapy, Combination; Europe; Humans; Immunosuppressive Agents; Inflamm | 2012 |
[Corticosteroid therapy for nephrotic syndrome].
Topics: Drug Resistance; Drug Therapy, Combination; Femur Head Necrosis; Fractures, Spontaneous; Humans; Imm | 2004 |
Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis?
Topics: Animals; Antibodies, Protozoan; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents | 1995 |
Increased circulating levels of interleukin-5 in a case of steroid-resistant hypereosinophilic syndrome with ileal involvement. Longcope Firm of the Osler Housestaff.
Topics: Adult; Antibodies; Drug Resistance; Drug Therapy, Combination; Gastroenteritis; Humans; Hypereosinop | 1994 |
Mortality associated with concurrent strongyloidosis and cytomegalovirus infection in a patient on steroid therapy.
Topics: Anti-Inflammatory Agents; Cytomegalovirus Infections; Fatal Outcome; Humans; Immunocompromised Host; | 1999 |
Hodgkin's disease: clinical presentation and treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined | 2001 |
Allogeneic stem cell transplantation for Evans syndrome.
Topics: Adrenal Cortex Hormones; Adult; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Autoimmune Di | 2001 |
[Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Bleomycin; Dacarbazine; | 1991 |
11 trials available for prednisone and Opportunistic Infections
Article | Year |
---|---|
A Randomized Trial of Daily Prednisone versus Pulsed Dexamethasone in Treatment-Naïve Adult Patients with Immune Thrombocytopenia: EIS 2002 Study.
Topics: Adult; Aged; Dexamethasone; Drug Administration Schedule; Follow-Up Studies; Glucocorticoids; Humans | 2016 |
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study.
Topics: Adolescent; Adult; Aged; Child; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combin | 2010 |
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu | 2011 |
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu | 2011 |
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu | 2011 |
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu | 2011 |
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu | 2011 |
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu | 2011 |
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu | 2011 |
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu | 2011 |
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu | 2011 |
Reduced exposure to calcineurin inhibitors in renal transplantation.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal | 2007 |
Reduced exposure to calcineurin inhibitors in renal transplantation.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal | 2007 |
Reduced exposure to calcineurin inhibitors in renal transplantation.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal | 2007 |
Reduced exposure to calcineurin inhibitors in renal transplantation.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal | 2007 |
Reduced exposure to calcineurin inhibitors in renal transplantation.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal | 2007 |
Reduced exposure to calcineurin inhibitors in renal transplantation.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal | 2007 |
Reduced exposure to calcineurin inhibitors in renal transplantation.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal | 2007 |
Reduced exposure to calcineurin inhibitors in renal transplantation.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal | 2007 |
Reduced exposure to calcineurin inhibitors in renal transplantation.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal | 2007 |
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; | 1995 |
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; | 1995 |
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; | 1995 |
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; | 1995 |
A cost-effectiveness analysis of OKT3 induction therapy in cadaveric kidney transplantation.
Topics: Anti-Infective Agents; Azathioprine; Cadaver; Cost-Benefit Analysis; Cyclosporine; Drug Costs; Graft | 1996 |
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.
Topics: Acute Disease; Administration, Oral; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft R | 1999 |
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.
Topics: Acute Disease; Administration, Oral; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft R | 1999 |
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.
Topics: Acute Disease; Administration, Oral; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft R | 1999 |
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.
Topics: Acute Disease; Administration, Oral; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft R | 1999 |
Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German Pediatric Renal Transplantation Study Group.
Topics: Adolescent; Child; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Graft Rejection | 2001 |
Results of a triple induction regime with tacrolimus, mycophenolate mofetil, and prednisone in renal transplantation.
Topics: Adrenal Cortex Hormones; Age Factors; Creatinine; Drug Therapy, Combination; Female; Follow-Up Studi | 2002 |
Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.
Topics: Adult; Cause of Death; Combined Modality Therapy; Cyclophosphamide; Disease Susceptibility; Female; | 1991 |
Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Clinica | 1988 |
102 other studies available for prednisone and Opportunistic Infections
Article | Year |
---|---|
The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring Steroids.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Carcinoma, Non-Small-Cell Lung; Humans; Immunocomprom | 2022 |
[Cutaneous Scedosporium apiospermum infection in a patient on long-term systemic corticosteroids].
Topics: Aged, 80 and over; Dermatomycoses; Glucocorticoids; Hand; Humans; Immunocompromised Host; Male; Myco | 2019 |
Incidental COVID-19 in a heart-kidney transplant recipient with malnutrition and recurrent infections: Implications for the SARS-CoV-2 immune response.
Topics: Antibiotics, Antineoplastic; Bacteremia; BK Virus; Cardiomyopathy, Dilated; Cardiotoxicity; COVID-19 | 2020 |
Clinical characteristics and management of immune checkpoint inhibitor-related pneumonitis: A single-institution retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Beijing; Female; Glucocorticoids; Humans; Immune Checkpoint Inhibito | 2021 |
When to consider Pneumocystis jirovecii prophylaxis in HIV-negative patients.
Topics: Aged; Anti-Bacterial Agents; Bendamustine Hydrochloride; HIV Seronegativity; Humans; Immunocompromis | 2021 |
Disseminated Nocardiosis Associated with Treatment with Infliximab in a Patient with Ulcerative Colitis.
Topics: Colitis, Ulcerative; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agen | 2017 |
Disseminated nocardiosis with cerebral and subcutaneous lesions on low-dose prednisone.
Topics: Aged; Anti-Inflammatory Agents; Brain; Humans; Immunocompromised Host; Male; Nocardia Infections; Op | 2019 |
A case of severe cutaneous
Topics: Aged; Animals; Anti-Bacterial Agents; Crohn Disease; Fishes; Humans; Male; Mycobacterium Infections, | 2019 |
Invasive fungal infections in renal transplant recipients: about 11 cases.
Topics: Adult; Anti-Bacterial Agents; Coinfection; Female; Graft Rejection; Humans; Immunocompromised Host; | 2013 |
Herpes simplex virus reactivation and disease during treatment for childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Chil | 2014 |
[Chronic ulcer in nasal vestibule].
Topics: Chronic Disease; Diagnosis, Differential; Female; Granuloma, Lethal Midline; Humans; Immunocompromis | 2014 |
Opportunistic infections in patients with pemphigus.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Cytomegalovirus | 2014 |
Aggressive Cunninghamella pneumonia in an adolescent.
Topics: Adolescent; Anti-Inflammatory Agents; Cunninghamella; Humans; Hyperbilirubinemia; Male; Mucormycosis | 2014 |
Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients.
Topics: Adult; Animals; Antilymphocyte Serum; Blood Cell Count; Drug Therapy, Combination; Female; Graft Rej | 2015 |
[Pulmonary nodules in a patient on long-term steroid treatment].
Topics: Anti-Inflammatory Agents; Diagnosis, Differential; Female; Humans; Middle Aged; Mycobacterium Infect | 2008 |
[Pneumocystis pneumonia among patients with systemic diseases].
Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Cyclophosphamide; Drug Therapy, Combination; Granulo | 2009 |
[Mycobacterium neoaurum bacteremia in an immunodepressed patient].
Topics: Adult; Azathioprine; Bacteremia; Colitis, Ulcerative; Female; Humans; Immunocompromised Host; Immuno | 2009 |
Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Epidemiologic M | 2010 |
Central airways obstruction due to Aspergillus fumigatus after lung transplantation.
Topics: Airway Obstruction; Antifungal Agents; Aspergillus fumigatus; Bronchoscopy; Diagnosis, Differential; | 2009 |
Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment.
Topics: Anti-Infective Agents; Antifungal Agents; Glucocorticoids; Humans; Immunocompromised Host; Leukemia, | 2009 |
Swine H1N1 influenza in a post liver transplant patient.
Topics: Adult; Antiviral Agents; Critical Care; Diagnosis, Differential; Disease Outbreaks; Drug Resistance, | 2009 |
Atypical presentation of histoplasmosis in a patient with psoriasis and psoriatic arthritis on infliximab therapy.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Arthritis, Psoriatic; Drug Therapy, Combina | 2010 |
Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis.
Topics: Aged; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Immunocompromised Host; Immunosup | 2010 |
Borreliosis in a patient treated with anti-TNFα therapy: first case.
Topics: Anti-Bacterial Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Doxycycline; Drug Therapy, Combi | 2011 |
[Rash, fever, eosinophilia and elevated liver enzymes. DRESS syndrome (drug reaction or rash with eosinophilia and systemic symptoms)].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2010 |
Kaposi's sarcoma: an opportunistic infection by human herpesvirus-8 in ulcerative colitis.
Topics: Aged; Colitis, Ulcerative; Colonic Neoplasms; Herpesvirus 8, Human; Humans; Immunocompromised Host; | 2010 |
Crusted Norwegian scabies, an opportunistic infection, with tocilizumab in rheumatoid arthritis.
Topics: Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Arthr | 2011 |
PCP chemoprophylaxis is essential for lymphopenic dermatomyositis patients treated with immunomodulators.
Topics: Chemoprevention; Dermatomyositis; Humans; Inflammation Mediators; Lymphopenia; Male; Middle Aged; Op | 2011 |
Cerebellar Cladophialophora bantiana infection in a patient with marginal zone lymphoma treated with immunochemotherapy including rituximab.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nerv | 2011 |
Cutaneous fusariosis developing in a post-irradiation site.
Topics: Adult; Combined Modality Therapy; Cyclosporine; Debridement; Dermatomycoses; Female; Fusarium; Human | 2011 |
Nocardia infection in a renal transplant recipient.
Topics: Acetamides; Anti-Infective Agents; Antifungal Agents; Cyclosporine; Drug Therapy, Combination; Epidu | 2011 |
Pneumocystis pneumonia in patients with immunobullous dermatoses.
Topics: Aged; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middl | 2011 |
Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2013 |
Fatal invasive aspergillosis of the larynx.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Aspergillosis; Consolidation Chemother | 2013 |
Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Child; Child, Preschool; Female; Graft v | 2002 |
[Atypical cytomegalovirus in renal transplantation: a new form of presentation].
Topics: Aged; Cytomegalovirus; Cytomegalovirus Infections; Disease Susceptibility; Duodenal Ulcer; Gastroint | 2002 |
Nocardiosis presenting as an anterior mediastinal mass in a patient with sarcoidosis.
Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Mediastinal Diseases; Nocardia Infections; Opportun | 2002 |
Pneumocystis carinii in a patient with hypercalcemia and renal failure secondary to sarcoidosis.
Topics: CD4 Lymphocyte Count; Drug Therapy, Combination; Humans; Hypercalcemia; Immune Tolerance; Male; Midd | 2002 |
[Pancytopenia after viral infection in St. n. malignant lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality The | 2003 |
Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; | 2003 |
Disseminated cytomegalovirus disease as a cause of prolonged fever in a bullous pemphigoid patient under systemic steroid therapy.
Topics: Aged; Biopsy, Needle; Cytomegalovirus Infections; Fever; Follow-Up Studies; Ganciclovir; Humans; Imm | 2003 |
Ambivalence of CD4 lymphocytopenia in sarcoidosis.
Topics: Adult; Bronchoalveolar Lavage Fluid; Female; Glucocorticoids; Humans; Male; Opportunistic Infections | 2003 |
Pneumocystis carinii pneumonia in chronic lymphocytic leukaemia.
Topics: Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Dyspnea; Fatal | 2004 |
[Invasive infection by Aspergillus terreus treated successfully with liposomal amphotericin B].
Topics: Aged; Amphotericin B; Antifungal Agents; Antiphospholipid Syndrome; Aspergillosis; Aspergillus; Auto | 2004 |
Mycobacterium xenopi infection in an immunosuppressed patient with Crohn's disease.
Topics: Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Diagnosis, Differential; Humans; Immunocompro | 2004 |
Disseminated histoplasmosis presenting as pancytopenia in a methotrexate-treated patient.
Topics: Aged; Arthritis, Rheumatoid; Diagnosis, Differential; Histoplasma; Histoplasmosis; Humans; Male; Met | 2004 |
Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Biopsy, Needle; Crohn Disease; Drug Therapy, Combinat | 2004 |
[Endogenous Candida endophthalmitis combined with severe general diseases].
Topics: Aged; Amphotericin B; Anterior Chamber; Antifungal Agents; Candidiasis; Endophthalmitis; Female; Fun | 2005 |
Fungal infections as a complication of therapy for sarcoidosis.
Topics: Antifungal Agents; Cryptococcosis; Humans; Immunocompromised Host; Immunosuppressive Agents; Methotr | 2005 |
Could Candida dubliniensis be involved in lung fungus balls?
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bronchoalveolar Lavage Fluid; Candida; C | 2005 |
Mycophenolate mofetil in dermatomyositis: is it safe?
Topics: Adult; Aged; Bronchopneumonia; Dermatomyositis; Drug Administration Schedule; Drug Therapy, Combinat | 2006 |
[Cutaneous leishmaniasis in polymyositis].
Topics: Adult; Animals; Anti-Inflammatory Agents; Female; Glucocorticoids; Humans; Immunoglobulins, Intraven | 2006 |
[Cryptococcal disease and immunosuppressive treatment].
Topics: Aged, 80 and over; Disease Susceptibility; Female; HIV Seronegativity; Humans; Immunocompromised Hos | 2006 |
Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-alpha therapy.
Topics: Adalimumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents | 2007 |
Phaeohyphomycosis and Mycobacterium fortuitum abscesses in a patient receiving corticosteroids for sarcoidosis.
Topics: Abscess; Adult; Dermatomycoses; Female; Humans; Immunocompromised Host; Mycobacterium Infections, No | 1995 |
Invasive aspergillosis. A complication of treatment of temporal arteritis.
Topics: Aged; Aged, 80 and over; Aspergillosis; Aspergillus fumigatus; Brain; Fatal Outcome; Female; Giant C | 1995 |
Bacterial esophagitis associated with CD4+ T-lymphocytopenia without HIV infection. Possible role of corticosteroid treatment.
Topics: Aged; Aged, 80 and over; Bacterial Infections; Esophagitis; Female; Humans; Immunocompromised Host; | 1995 |
Pneumocystis carinii pneumonia after liver transplantation in adults.
Topics: Adult; Female; Graft Rejection; Humans; Immunosuppression Therapy; Liver Diseases; Liver Function Te | 1994 |
Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis.
Topics: Female; Granulomatosis with Polyangiitis; Humans; Immunosuppression Therapy; Immunosuppressive Agent | 1995 |
Fatal invasive aspergillosis during cyclosporine and steroids treatment for Crohn's disease.
Topics: Adult; Aspergillosis; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Fatal Outcome; Female; | 1995 |
[Eosinophilic endomyocarditis post partum or pregnancy-related cardiomyopathy].
Topics: Adult; Azathioprine; Biopsy; Combined Modality Therapy; Cytomegalovirus Infections; Diagnosis, Diffe | 1994 |
Late listeriosis after fludarabine plus prednisone treatment.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Fatal Outcome; Humans; | 1994 |
Development of panhypogammaglobulinaemia in a patient with systemic lupus erythematosus.
Topics: Administration, Oral; Adult; Agammaglobulinemia; Azathioprine; Bacterial Infections; Cyclophosphamid | 1994 |
[Cutaneous Alternaria infection occurring in the course of a treated pemphigus].
Topics: Aged; Alternaria; Dermatomycoses; Humans; Male; Opportunistic Infections; Pemphigus; Prednisone | 1994 |
[Detection of an unusual varicella zoster virus infection in an immunosuppressed patient with polymerase chain reaction].
Topics: Acyclovir; Aged; Azathioprine; Chickenpox; Cytopathogenic Effect, Viral; Female; Herpesvirus 3, Huma | 1994 |
[Lupus erythematosus disseminatus and Pneumocystis carinii pneumonia].
Topics: Bronchoalveolar Lavage Fluid; Cyclophosphamide; Female; Humans; Lung; Lupus Erythematosus, Systemic; | 1993 |
Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases.
Topics: Adult; Aged; Aged, 80 and over; Connective Tissue Diseases; Cyclophosphamide; Female; Humans; Immuno | 1994 |
De novo hypertension after liver transplantation.
Topics: Adult; Azathioprine; Cyclosporine; Humans; Hypertension; Immunosuppression Therapy; Labetalol; Liver | 1993 |
Wegener granulomatosis in children and adolescents: clinical presentation and outcome.
Topics: Adolescent; Adult; Age Factors; Child; Cyclophosphamide; Eye Diseases; Female; Follow-Up Studies; Gl | 1993 |
Cutaneous phaeohyphomycosis due to Alternaria alternata responding to itraconazole.
Topics: Aged; Aged, 80 and over; Alternaria; Dermatomycoses; Hand Dermatoses; Humans; Male; Nephrotic Syndro | 1993 |
Bilateral herpes simplex virus keratitis in a patient with pemphigus vulgaris.
Topics: Aged; Glucocorticoids; Humans; Keratitis, Herpetic; Male; Opportunistic Infections; Pemphigus; Predn | 1996 |
Opportunistic infections in patients with temporal arteritis treated with corticosteroids.
Topics: Aged; Anti-Inflammatory Agents; Bacteremia; Cryptococcosis; Fatal Outcome; Giant Cell Arteritis; Hum | 1997 |
Identification of HHV-8 DNA in the skin lesions of Kaposi's sarcoma in an immunosuppressed patient with bullous pemphigoid.
Topics: Aged; Aged, 80 and over; Azathioprine; DNA, Viral; Female; Herpesvirus 8, Human; Humans; Immunosuppr | 1997 |
Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation | 1997 |
Disseminated Rhodococcus equi and Nocardia farcinica infection in a patient with sarcoidosis.
Topics: Actinomycetales Infections; Glucocorticoids; HIV Seronegativity; Humans; Immunocompromised Host; Mal | 1998 |
Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia.
Topics: Anti-Infective Agents; Antifungal Agents; Drug Therapy, Combination; Female; Glucocorticoids; HIV In | 1998 |
Disseminated histoplasmosis successfully treated with liposomal amphotericin B following azathioprine therapy in a patient from a nonendemic area.
Topics: Adult; Amphotericin B; Antifungal Agents; Azathioprine; Bone Marrow Cells; Drug Carriers; Drug Thera | 1998 |
Nocardiosis in a recently transplanted renal patient.
Topics: Diabetes Complications; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressiv | 1998 |
Infections in patients with chronic lymphocytic leukemia treated with fludarabine.
Topics: Analysis of Variance; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combine | 1998 |
Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study.
Topics: Adult; Azathioprine; Case-Control Studies; Cyclosporine; Cytomegalovirus Infections; Female; Humans; | 1998 |
Disseminated histoplasmosis and Wegener's granulomatosis.
Topics: Adult; Cyclophosphamide; Fatal Outcome; Female; Glucocorticoids; Granulomatosis with Polyangiitis; H | 1998 |
Clinical conference on management dilemmas: progressive pneumonia in a patient receiving long-term steroid therapy.
Topics: Aged; Anti-Inflammatory Agents; Antitubercular Agents; Biopsy; Diagnosis, Differential; Drug Therapy | 1999 |
Primary subcutaneous nocardial infection in a SLE patient.
Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Immunocompromised Host; Lupus Erythematosus, System | 1999 |
[Subcutaneous mycosis due to Scopulariopsis brevicaulis in an immunocompromised patient].
Topics: Biopsy; Cyclosporine; Dermatomycoses; Humans; Immunocompromised Host; Immunosuppressive Agents; Live | 2001 |
A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillo | 2001 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 36-2001. Acute febrile respiratory illness in a 57-year-old man with recurrent pulmonary disorders.
Topics: Anti-Inflammatory Agents; Cough; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; Fever; H | 2001 |
Toxoplasmic encephalitis in a non-HIV patient with follicular lymphoma.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive | 2002 |
Failure of G-CSF therapy in neutropenia associated with Sjögren's syndrome.
Topics: Amikacin; Anemia; Anti-Bacterial Agents; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; | 2002 |
Complications of corticosteroid therapy in presumptive temporal arteritis.
Topics: Aged; Autopsy; Biopsy; Female; Giant Cell Arteritis; Humans; Male; Opportunistic Infections; Prednis | 1976 |
Cytomegalovirus infection in children with blood diseases.
Topics: Adolescent; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; C | 1992 |
Pneumonia and pneumonitis in childhood malignancy.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; C | 1992 |
Nonresolving pneumonia in steroid-treated patients with obstructive lung disease.
Topics: Aged; Aged, 80 and over; Aspergillosis; Aspergillus fumigatus; Asthma; Female; Forced Expiratory Vol | 1992 |
Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT).
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 1991 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Salmonella arizona arthritis and septicemia associated with rattlesnake ingestion by patients with connective tissue diseases. A dangerous complication of folk medicine.
Topics: Adolescent; Adult; Animals; Arthritis, Infectious; Azathioprine; Connective Tissue Diseases; Drug Th | 1991 |
Immunosuppressive therapy of pemphigus vulgaris complicated by Nocardia pneumonia. Gold as an alternate therapy.
Topics: Azathioprine; Candidiasis; Female; Gold Sodium Thiomalate; Humans; Injections, Intramuscular; Middle | 1990 |
Multiple brain abscesses from isolated cerebral mucormycosis.
Topics: Adult; Brain Abscess; Cyclophosphamide; Female; Frontal Lobe; Humans; Lupus Erythematosus, Systemic; | 1990 |
Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Effect of duration of ALG therapy.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Drug Administration Schedule; Graft Rejec | 1989 |
Serious infectious complications of corticosteroid therapy for COPD.
Topics: Aged; Aged, 80 and over; Female; Humans; Lung Diseases, Obstructive; Male; Methylprednisolone; Middl | 1989 |
Pulmonary infections in renal transplantation patients treated with cyclosporine.
Topics: Adult; Cyclosporins; Cytomegalovirus Infections; Female; Humans; Kidney Transplantation; Male; Middl | 1988 |
A prospective study on infection with cytomegalovirus in renal allograft recipients immunosuppressed with cyclosporine A and low dose prednisone.
Topics: Adolescent; Adult; Antibodies, Viral; Child; Cyclosporins; Cytomegalovirus; Cytomegalovirus Infectio | 1987 |
First month cyclosporine A sparing in renal transplantation.
Topics: Creatinine; Cyclosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Graft Reje | 1988 |